Skip to content
Research Article Open access CC BY 3.0

Knowledge and Practice Pattern of Malaria Prevention and Control in Pregnancy by Healthcare Providers within the Context of Focused Antenatal Care in Enugu State, Nigeria

U. Igboeli Nneka, O. Adibe Maxwell, C. Aguwa Nze

International Journal of TROPICAL DISEASE & Health · pp. 905–916 · Published 16 Jun 2014

10.9734/IJTDH/2014/10598

Abstract

Aim: To assess the knowledge and practice pattern of malaria prevention and control in pregnancy by healthcare providers within the context of focused antenatal care. Study Design: A prospective cross-sectional survey study. Place and Duration of Study: Health facilities from the three levels of care in Enugu, Southeast Nigeria, between July to September, 2011. Methodology: Data collection was with a pre-tested structured questionnaire administered to the healthcare providers that were directly involved in antenatal care services. They consisted of 113 respondents (Doctors, Pharmacists and Nurses). The questionnaire elicited information on their knowledge about malaria, treatment and prevention practices. Results: Many providers had high knowledge of malaria in pregnancy. Malaria diagnosis was mainly by symptom recognition 102 (90.3%). Treatment of uncomplicated malaria was mainly with Artemisinin-Combination Therapies (ACTs) both in the 1st 43 (38.1%), 2nd and 3rd 55 (48.7%) trimesters. Severe malaria was also treated with ACTs 24 (24.8%) by majority of the providers. Quinine was used by only few providers in treating 1st trimester uncomplicated malaria 8 (7.1%) and severe malaria 19 (16.8%). Sulphadoxine-Pyrimethamine (SP) was mostly used by the providers 88 (77.9%) for malaria prevention while proguanil 29 (25.4%) was usually given as an alternative to SP. SP was given by directly-observed treatment by 55.8% of the providers while only 18.6% actually withheld folic acid supplementation for the recommended two weeks following SP administration. Other antenatal care (ANC) - MIP integrated services rendered by the providers were Iron folate supplementation 90 (79.6%), Insecticide-Treated-Nets (ITNs) Provision 87 (77.0%) and Deworming 30 (26.5%). Conclusion: The level of knowledge on malaria in pregnancy was high among the providers. However, there was sub-optimal delivery of current best practices, especially in the area of drug prescriptions for both treatment and prevention. Multiple strategies are required to improve healthcare providers’ practices in MIP prevention and control.

Malaria prevention pregnancy knowledge practices

References (22)

  1. 1 Epidemiology and burden of malaria in pregnancy [DOI]
  2. 2 A Review of Malaria Diagnostic Tools: Microscopy and Rapid Diagnostic Test (RDT) [DOI]
  3. 3 The public health impact of chloroquine resistance in Africa [DOI]
  4. 4 Antenatal care in developing countries: promises achievements and missed opportunities. An analysis of trends levels and differentials 1990-2001.
  5. 5 The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi [DOI]
  6. 6 Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study [DOI]
  7. 7 Comparison of Intermittent Preventive Treatment with Chemoprophylaxis for the Prevention of Malaria during Pregnancy in Mali [DOI]
  8. 8 Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania [DOI]
  9. 9 Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study [DOI]
  10. 10 Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine‐pyrimethamine treatment failure and gametocyte carriage in northern Ghana [DOI]
  11. 11 Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia [DOI]
  12. 12 Artesunate: developmental toxicity and toxicokinetics in monkeys [DOI]
  13. 13 Timing of intermittent preventive treatment for malaria during pregnancy and the implications of current policy on early uptake in north-east Tanzania [DOI]
  14. 14 Sensitive periods for developmental toxicity of orally administered artesunate in the rat [DOI]
  15. 15 Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women [DOI]
  16. 16 Patterns of case management and chemoprevention for malaria-in-pregnancy by public and private sector health providers in Enugu state, Nigeria [DOI]
  17. 17 A randomized, placebo‐controlled trial of intermittent preventive treatment with sulphadoxine–pyrimethamine in Gambian multigravidae [DOI]
  18. 18 Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV.
  19. 19 Malaria in pregnancy: Access to effective interventions in Africa [DOI]
  20. 20 Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid [DOI]
  21. 21 Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance [DOI]
  22. 22 Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. III. Serologic studies [DOI]

Cited by 7

Antimalarial treatment patterns among pregnant women attending antenatal care clinics in south east Nigeria and the future implications

Charles Ezenduka, Chizoba Nworgu, Brian Barr Godman · International Journal of Clinical Practice · 2016

Prevention of malaria in pregnancy

Meghna Desai, Jenny Hill, Silke Fernandes · The Lancet Infectious Diseases · 2018

Treatment of uncomplicated and severe malaria during pregnancy

Umberto D'Alessandro, Jenny Hill, Joel Tarning · The Lancet Infectious Diseases · 2018

Showing 3 of 7 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

32

Page views

0

PDF downloads

3

Outbound clicks

7

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.